NCT02799771

HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION

Observational Study of Incident Patients With Pre Capillary Pulmonary Hypertension and Interstitial Lung Disease

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 210 (actual)
• Sponsor: Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

HYPID-2 study is an extension of HYPID study (NCT01443598) : HYPID-2 is also an observational and prospective study of patients with interstitial lung disease and pre capillary hypertension diagnosed by right heart sided catheterization. It concerns only incident patients (i.e patients included within 6 months after PH diagnosis) whereas HYPID concerned prevalent and incident cases. The primary aim is the same than HYPID : identify prognostic factors

Detailed description

Pre capillary pulmonary hypertension (PH) may be present in patients with diffuse interstitial lung disease. In this context, PH represents an important factor of morbidity and mortality for these patients. As in HYPID, the main purpose of HYPID-2 is to determine predictive factors of mortality within this cohort of incident patients (i.e patients included within 6 months after PH diagnosis). In order to reach that aim,the study includes an evaluation based on exams conducted for the routine follow-up of incident patients. Each incident patient will be followed during 2 years at least.

Conditions

• Pulmonary Arterial Hypertension
• Diffuse Interstitial Lung Disease

Timeline

• Start date: 2013-02-01
• Primary completion: 2018-02-01
• Completion: 2022-02-01
• First posted: 2016-06-15
• Last updated: 2022-08-03

Locations

1 site across 1 country: France